)
Reliq Health Technologies (RHT) investor relations material
Reliq Health Technologies Investor Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Corporate and trading status
Currently under a Cease Trade Order, with trading suspended until financial statements are filed and compliance is restored.
Recently moved from TSX Venture to NEX Exchange, with trading symbol changed to RHT.H; no change to company name or identifiers.
Plans to reapply for TSX Venture listing once financials are filed and standing is restored.
Financial and operational highlights
Achieved several profitable quarters and expects continued client and patient growth.
Maintains strong long-term margins: 70% gross margin and 40% EBITDA margin targeted for 2025.
Adds about one physician practice per week and has expanded into respiratory therapy and pediatric monitoring.
Over 500,000 eligible patients under contract, with a focus on converting them to billable patients.
Strategic priorities and outlook
Key deliverables for 2024: timely filing of financial statements and improved corporate communications.
2025 focus shifts to profitability and cash collection, with cost control and maximizing billable patients.
Launching a new version of iUGO Care in 2025, designed for easier updates and lower operational costs.
Plans to expand mental health services, grow in existing geographies, and define an AI/machine learning roadmap.
- TimeTickerHeadlineOpen
- MILDEF
Record-breaking growth and profitability in 2025, fueled by acquisitions and strong order intake. - MYCR
Q4 sales down 2%, order intake down 19%, but record full-year sales and four acquisitions. - VF
Underlying EBIT up 81% to SEK 30.9 bn; profit down 41% amid divestments and major investments. - ADDT
Earnings and margins rose, acquisitions accelerated, and outlook remains positive. - NCC
Record profits in core segments, major impairment, dividend maintained, outlook positive. - 7004
Order intake and sales rose, but losses and technical issues led to lower profit forecasts. - KIO
Headline earnings per share expected up 11–23% on higher prices and stable operations. - AAL
2026 copper and diamond guidance lowered, premium iron ore guidance raised, portfolio reshaping ongoing. - VRCI
Revenue rose to $3.8m in FY25, fueled by Tutivia test adoption and expanded US coverage. - SYNC
NAV per share rose 3.6% as late-stage clinical assets and Beacon's uplift drove portfolio gains.
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)